No abstract available
Keywords:
angiotensin; diuresis; ejection fraction; heart failure; hypertension.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aminobutyrates / adverse effects
-
Aminobutyrates / therapeutic use*
-
Angiotensin II Type 1 Receptor Blockers / adverse effects
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
-
Biphenyl Compounds
-
Drug Combinations
-
Heart Failure / complications
-
Heart Failure / diagnosis
-
Heart Failure / physiopathology
-
Heart Failure / surgery*
-
Heart Transplantation*
-
Hemodynamics / drug effects
-
Humans
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / etiology
-
Hypertension, Pulmonary / physiopathology
-
Neprilysin / antagonists & inhibitors*
-
Protease Inhibitors / adverse effects
-
Protease Inhibitors / therapeutic use*
-
Recovery of Function
-
Tetrazoles / adverse effects
-
Tetrazoles / therapeutic use*
-
Time Factors
-
Treatment Outcome
-
Valsartan
-
Waiting Lists*
Substances
-
Aminobutyrates
-
Angiotensin II Type 1 Receptor Blockers
-
Biphenyl Compounds
-
Drug Combinations
-
Protease Inhibitors
-
Tetrazoles
-
Valsartan
-
Neprilysin
-
sacubitril and valsartan sodium hydrate drug combination